Drawing for SLEEP ENHANCEMENT

USPTO serial 87866087

SLEEP ENHANCEMENT

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
FROMM, MARTHA L
Law office
TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SLEEP ENHANCEMENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David H. Chervitz

DAVID H CHERVITZ458 WHITESTONE FARM DRIVECHESTERFIELD, MO 63017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
020Adjustable bed assemblies, namely, bed frames and bed basesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 21, 2020MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Apr 14, 2020ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Apr 14, 2020EXPTEXPARTE APPEAL TERMINATED—
Jan 30, 2020EXPAEX PARTE APPEAL-REFUSAL AFFIRMED—
Sep 26, 2019RBFTREPLY BRIEF FILED - CHECK TTAB FILES—
Sep 11, 2019GNSNNOTIFICATION OF EXAMINERS STATEMENT E-MAILED—
Sep 11, 2019GNESEXAMINERS STATEMENT E-MAILED—
Sep 11, 2019CNESEXAMINERS STATEMENT - COMPLETED—
Aug 6, 2019JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Jun 7, 2019EXPIEX PARTE APPEAL-INSTITUTED—
Jun 7, 2019EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Dec 7, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Dec 7, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 7, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 10, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 9, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 9, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 10, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 10, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2018DOCKASSIGNED TO EXAMINER—
Apr 14, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 10, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance